SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001415889-14-002566
Filing Date
2014-08-19
Accepted
2014-08-19 16:30:51
Documents
3
Period of Report
2014-08-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 ecte8kaug192014.htm 8-K 29538
2 PRESS RELEASE ISSUED BY THE COMPANY ON AUGUST 14, 2014 ex99-1.htm EX-99.1 130803
3 ex99-181.jpg GRAPHIC 10975
  Complete submission text file 0001415889-14-002566.txt   177161
Mailing Address 8 PENN CENTER 1628 JFK BLVD, SUITE 300 PHILADELPHIA PA 19103
Business Address 8 PENN CENTER 1628 JFK BLVD, SUITE 300 PHILADELPHIA PA 19103 215-717-4100
Echo Therapeutics, Inc. (Filer) CIK: 0001031927 (see all company filings)

IRS No.: 411649949 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35218 | Film No.: 141052418
SIC: 3845 Electromedical & Electrotherapeutic Apparatus